Priscilla Ying Hsue MD
Adult Congenital Heart Disease
Associate Professor, Medicine, University of California, San Francisco, School of Medicine
Join to View Full Profile
100 Medical Plaza Driveway Suite 630Los Angeles, CA 90095
Phone+1 310-825-9011
Fax+1 415-206-3872
Dr. Hsue is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Cardiovascular Disease, 1999 - 2002- University of California (San Francisco)Residency, Internal Medicine, 1996 - 1999
- University of California San Francisco School of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 1998 - 2026
American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Effect of Raltegravir on Endothelial Function in HIV-Infected Patients Start of enrollment: 2009 Jan 01
- Effect of Maraviroc on Endothelial Function in HIV-Infected Patients Start of enrollment: 2010 Jan 01
- Atherosclerosis in Rheumatoid Arthritis Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: rationale and protocol for the COMBO-H...Colette DeJong, Matthew S Durstenfeld, Jonathan D Davis, Christina S Wang, Elise D Riley
BMJ Open. 2025-03-21 - Multicenter study of heart failure phenotypes and physician-adjudicated etiologies in people with HIV.Nour Beydoun, Robin M Nance, Matthew S Durstenfeld, Alexander P Hoffmann, Bridget M Whitney
AIDS. 2025-03-18 - Prototyping and Manufacturing of Customized Over-Encapsulated Polypills for Heart Failure with Reduced Ejection Fraction in a Safety-Net Healthcare System.Colette DeJong, Matthew S Durstenfeld, Jonathan Davis, Christina S Wang, Justin Chen
Journal of Cardiac Failure. 2025-03-12
Journal Articles
- Association of Viral Persistence and Atherosclerosis in Adults with Treated HIV InfectionJeffrey N Martin, Steven G Deeks, Priscilla Y Hsue, JAMA Network Open
- Inflammation, Immunity, and Infection in AtherothrombosisPaul M Ridker, Valentin Fuster, Priscilla Y Hsue, Peter Libby, ScienceDirect
- Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Grou...Steven G Deeks, James H Stein, Carl Fichtenbaum, Judith S Currier, Priscilla Y Hsue, Eric S Daar, Ahmed Tawakol, Michael Lederman, Tanvir Bell, Diane Havlir, Clinical Infectious Diseases
Press Mentions
Injectable Medications Prove Effective at Lowering LDL CholesterolJanuary 17th, 2025- Chinese American Immigrants Face Higher Risk of Cardiovascular Disease Depending on Length of Residence and Location in the U.S.September 5th, 2024
- How Prolonged COVID-19 Influences Physical PerformanceOctober 21st, 2022
- Join now to see all
Grant Support
- Heart and Lung Outcomes Post-TB (HALO Post-TB)UNIVERSITY OF CALIFORNIA LOS ANGELES2024–2029
- REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRDVANDERBILT UNIVERSITY MEDICAL CENTER2024–2028
- Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Cholesterol and inflammation Lowering via BEmpedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)UNIVERSITY OF CALIFORNIA LOS ANGELES2022–2027
- In Vivo PET Imaging of HIV InfectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2026
- Role of Hematopoietic System and Proteomics in HIV-Associated CardiovascularDiseaseUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2025
- Cell-Type Specific Mechanisms of HIV CardiomyopathyUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2025
- Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV InfectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
- Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV InfectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
- Inflammation, Viral Replication, And Atherosclerosis In Treated HIV InfectionNational Heart, Lung, And Blood Institute2008–2011
- Epidemiology And Pathogenesis Of Pulmonary Hypertension In HIV PatientsNational Heart, Lung, And Blood Institute2007–2011
- Pathogenesis Of Atherosclerosis In HIV Patients On HaartNational Institute Of Allergy And Infectious Diseases2005–2009
- Immunologic And Inflammatory Factors In Patients With HIVNational Center For Research Resources2005
- HHV-8 And Pulmonary Arterial Pressures In Patients With HIV InfectionNational Center For Research Resources2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
